|
Secondary malignant neoplasm of lung
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
5-FU-mediated augmented lung metastasis was associated with increases in intrapulmonary neutrophil numbers and expression of neutrophilic chemokines, Cxcl1 and Cxcl2 in tumor cells, with few effects on intrapulmonary T-cell or macrophage numbers.
|
29643149 |
2018 |
|
Endotoxemia
|
0.020 |
AlteredExpression
|
phenotype |
BEFREE |
Endotoxemia in the acute phase was associated with: (1) pathological changes in lung morphology; (2) increase of ROS generation; (3) enhanced expression of CxCL2; and (4) a gradual decrease of VO<sub>2</sub> and V<sub>E</sub>.
|
28531802 |
2017 |
|
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Tumor cell growth in Emilin2 null mice was impaired as well as the expression of MIP-2.
|
29483644 |
2018 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
CXCL2 secreted from TAM-like macrophages plays an important role in tumour invasiveness.
|
27425378 |
2016 |
|
Pyelonephritis
|
0.010 |
Biomarker
|
disease |
BEFREE |
MIP‑2 concentration in kidney homogenates from TcpC‑secreting UPEC CFT073 (TcpCwt) murine pyelonephritis models was significantly higher compared with that in kidney homogenates from tcpC knockout CFT073 (TcpC‑/‑) models.
|
28765918 |
2017 |
|
Laryngeal Squamous Cell Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
GROβ protein expression in LSCC was associated with tumor-node-metastasis stage, lymph node metastasis and histopathological grade.
|
28927085 |
2017 |
|
Secondary malignant neoplasm of lymph node
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
GROβ protein expression in LSCC was associated with tumor-node-metastasis stage, lymph node metastasis and histopathological grade.
|
28927085 |
2017 |
|
Osteopenia
|
0.010 |
Biomarker
|
disease |
BEFREE |
CXCL2 neutralization within the bone marrow by using antibody alleviated bone loss in mice, indicating a negative role of CXCL2 in bone formation.
|
31292171 |
2019 |
|
Middle Cerebral Artery Syndrome
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke.
|
12374626 |
2002 |
|
Middle Cerebral Artery Thrombosis
|
0.300 |
Biomarker
|
disease |
CTD_human |
A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke.
|
12374626 |
2002 |
|
Middle Cerebral Artery Occlusion
|
0.300 |
Biomarker
|
disease |
CTD_human |
A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke.
|
12374626 |
2002 |
|
Infarction, Middle Cerebral Artery
|
0.300 |
Biomarker
|
disease |
CTD_human |
A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke.
|
12374626 |
2002 |
|
Middle Cerebral Artery Embolus
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke.
|
12374626 |
2002 |
|
Left Middle Cerebral Artery Infarction
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke.
|
12374626 |
2002 |
|
Embolic Infarction, Middle Cerebral Artery
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke.
|
12374626 |
2002 |
|
Thrombotic Infarction, Middle Cerebral Artery
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke.
|
12374626 |
2002 |
|
Right Middle Cerebral Artery Infarction
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke.
|
12374626 |
2002 |
|
Sepsis
|
0.040 |
GeneticVariation
|
disease |
LHGDN |
A CXCL2 tandem repeat promoter polymorphism is associated with susceptibility to severe sepsis in the Spanish population.
|
16421598 |
2006 |
|
Reperfusion Injury
|
0.500 |
Biomarker
|
disease |
RGD |
A novel ELR-CXC chemokine antagonist reduces intestinal ischemia reperfusion-induced mortality, and local and remote organ injury.
|
19691980 |
2010 |
|
Shigella Infections
|
0.020 |
Biomarker
|
group |
BEFREE |
A positive correlation was observed between pro-inflammatory cytokines IL-1β, NLRP3, and CXCL2 with abundance of the inflammatory bacteria taxon Escherichia/Shigella (rho = 0.60, p < 0.001; rho = 0.57, p < 0.001; and rho = 0.30, p = 0.007, respectively) and a negative correlation with the anti-inflammatory E. rectale (rho = -0.48, p < 0.001; rho = -0.25, p = 0.024; rho = -0.49, p < 0.001).
|
27776263 |
2017 |
|
Pneumonia, Viral
|
0.200 |
Biomarker
|
disease |
RGD |
A rat model of picornavirus-induced airway infection and inflammation.
|
19671179 |
2009 |
|
Leukemia, Myelocytic, Acute
|
0.020 |
Biomarker
|
disease |
BEFREE |
A-kinase interacting protein 1 might serve as a novel biomarker for worse prognosis through the interaction of chemokine (C-X-C motif) ligand 1/chemokine (C-X-C motif) ligand 2 in acute myeloid leukemia.
|
31617252 |
2020 |
|
Chronic Obstructive Airway Disease
|
0.310 |
Biomarker
|
disease |
CTD_human |
Aberrantly activated EGFR contributes to enhanced IL-8 expression in COPD airways epithelial cells via regulation of nuclear FoxO3A.
|
23099361 |
2013 |
|
Chronic Airflow Obstruction
|
0.300 |
Biomarker
|
disease |
CTD_human |
Aberrantly activated EGFR contributes to enhanced IL-8 expression in COPD airways epithelial cells via regulation of nuclear FoxO3A.
|
23099361 |
2013 |
|
Alcoholic Liver Diseases
|
0.200 |
Biomarker
|
group |
RGD |
Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat.
|
10498645 |
1999 |